Alesia Tietze | Medicinal Chemistry in Cancer | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Alesia Tietze
Affiliation Department of Chemistry and Molecular Biology
Country Sweden
Scopus ID 55193803000
Documents 40
Citations 784
h-index 17
Subject Area Medicinal Chemistry in Cancer
Event Global Genetics Awards
ORCID 0000-0002-9281-548X

Alesia Tietze
Department of Chemistry and Molecular Biology

Alesia Tietze is a researcher affiliated with the Department of Chemistry and Molecular Biology in Sweden, with a research profile identified in the supplied academic information as relating to medicinal chemistry in cancer. The profile is associated with 40 Scopus-indexed documents, 784 citations, and an h-index of 17. These bibliometric indicators provide a quantitative view of research visibility and scholarly impact, while the award assessment itself should be based on the complete research record and independently verified evidence. [3]

Abstract

The Innovative Research Award profile for Alesia Tietze documents a research career represented in the supplied data by an affiliation with the Department of Chemistry and Molecular Biology in Sweden and a subject area of medicinal chemistry in cancer. The associated Scopus record is reported as containing 40 documents, 784 citations, and an h-index of 17. [1] These metrics can be used as supporting indicators of scholarly activity and citation reach, but they do not independently establish the novelty, methodological quality, translational significance, or originality of individual research contributions. The researcher is also associated with an ORCID identifier, providing a persistent identifier for distinguishing the scholarly record. [2]

Keywords

Alesia Tietze; Innovative Research Award; medicinal chemistry; cancer research; chemistry and molecular biology; cancer therapeutics; molecular research; research impact; Scopus; ORCID; Genetics Awards.

Introduction

Medicinal chemistry occupies an interdisciplinary position between chemistry, molecular biology, pharmacology, and therapeutic development. Research in this area may involve the design, synthesis, characterization, optimization, and biological evaluation of compounds intended to address disease-associated molecular targets. In cancer research, medicinal chemistry can intersect with studies of molecular mechanisms, therapeutic targets, biomarkers, drug resistance, and precision-oriented treatment strategies.

Within this broad research environment, academic recognition generally requires consideration of both quantitative and qualitative evidence. Bibliometric indicators such as document counts, citation counts, and h-index values can provide useful measures of scholarly visibility, while publications, methodological contributions, collaborations, and demonstrable scientific outcomes provide additional context. The Genetics Awards program states that submitted research profiles may undergo screening, credential verification, cross-checking of submitted information, and committee review before selection. [3]

Research Profile

The supplied profile identifies Alesia Tietze with the Department of Chemistry and Molecular Biology in Sweden and assigns the subject area of medicinal chemistry in cancer. The reported Scopus information comprises 40 documents, 784 citations, and an h-index of 17. [1] Taken together, these values indicate a documented body of indexed scholarly output and citation activity.

The research profile should be interpreted in relation to the underlying publications rather than as a standalone ranking. Citation indicators can vary according to database coverage, publication type, disciplinary citation practices, author disambiguation, and the date on which the record is consulted. The ORCID identifier supplied for the researcher offers an additional mechanism for connecting scholarly outputs to a persistent researcher identity. [2]

Research Contributions

Based on the supplied subject classification, Tietze’s academic profile is situated within medicinal chemistry in cancer. This field encompasses research that connects chemical science with biological and therapeutic questions relevant to oncology. The precise contribution of an individual researcher should, however, be established from verified publications, research projects, patents, datasets, collaborations, and other primary scholarly evidence rather than inferred solely from a subject-area label.

For an award evaluation, relevant evidence may include the originality of research questions, rigor of experimental or computational methods, reproducibility, significance of findings, contribution to interdisciplinary research, and potential relevance to cancer biology or therapeutic development. The Genetics Awards program identifies research excellence and related scientific contributions among the areas considered within its award framework. [3]

Publications

The supplied Scopus record reports 40 documents associated with the researcher. [1] Because individual publication titles, journals, publication years, authorship positions, and DOI identifiers were not supplied in the source information for this profile, specific publications are not enumerated here. This avoids attributing research findings or bibliographic details that have not been independently established.

For formal award documentation, the publication record can be verified through the researcher’s Scopus author profile and persistent ORCID identifier. Where individual publications are evaluated, DOI metadata should be checked against the publisher or DOI registration record before being included in a nomination dossier.

Research Impact

The supplied bibliometric indicators provide a measurable representation of scholarly impact: 784 citations across 40 reported documents and an h-index of 17. [1] These indicators may support an assessment of sustained research visibility, but they should be interpreted alongside publication quality, contribution to the scientific literature, collaboration, methodological innovation, and the broader significance of the research.

In the context of cancer-focused medicinal chemistry, research impact may also be considered through the extent to which scientific findings contribute to understanding disease mechanisms, identifying therapeutic opportunities, improving molecular tools, or informing subsequent research. Such outcomes require evidence from the underlying scholarly record and should not be inferred solely from citation statistics.

Award Suitability

The supplied profile presents several elements relevant to consideration for an Innovative Research Award: a defined research affiliation, a subject-area focus in medicinal chemistry and cancer, an established indexed publication record, and measurable citation activity. The reported h-index of 17 and 784 citations may serve as supporting bibliometric evidence of scholarly reach. [1]

Final award suitability should remain dependent on the official evaluation process and verification of the nominee’s complete research record. The Genetics Awards program describes a process involving submission screening, verification of credentials, cross-checking of information, committee review, and subsequent selection. [3] Accordingly, the present article should be understood as an academic recognition profile based on the supplied information rather than as an independent declaration of award selection.

Conclusion

Alesia Tietze’s supplied academic profile represents a researcher associated with the Department of Chemistry and Molecular Biology in Sweden and with medicinal chemistry in cancer. The reported Scopus indicators of 40 documents, 784 citations, and an h-index of 17 provide quantitative evidence of an established scholarly record. [1] The associated ORCID identifier further supports persistent scholarly identification. [2]

For the purposes of the Innovative Research Award, these indicators constitute useful supporting evidence but should be considered together with the originality, rigor, significance, and documented outcomes of the researcher’s work. A complete assessment should rely on verified publications and other primary academic evidence in accordance with the award’s stated evaluation procedures. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Alesia Tietze, Author ID 55193803000.

    Scopus.https://www.scopus.com/authid/detail.uri?authorId=55193803000

  2. ORCID. (n.d.). ORCID record: Alesia Tietze, ORCID iD 0000-0002-9281-548X.
    https://orcid.org/0000-0002-9281-548X

  3. Targeted sortase A inhibition by novel peptidomimetic antivirulents against staphylococcal infections

    https://pubmed.ncbi.nlm.nih.gov/41773879/

  4. DNA Scission by Non-Histidine Amino-Terminal Cu(II) and Ni(II) Binding-Like Peptides

    https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.70397

 Andrea Manica | Population genetics software | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Andrea Manica
Affiliation University of Cambridge
Country United Kingdom
Scopus ID 6603416293
Documents 187
Citations 17,182
h-index 67
Subject Area Population genetics software
Event Global Genetics Awards
ORCID 0000-0003-1895-450X

 Andrea Manica

University of Cambridge, United Kingdom

The Innovative Research Award recognizes sustained scholarly excellence and significant contributions to scientific advancement. Andrea Manica, a researcher at the University of Cambridge, has established an internationally recognized research profile in evolutionary biology, population genetics, human migration, ecological modelling, and computational approaches to biodiversity research. His scholarly publications, extensive citation record, and interdisciplinary collaborations demonstrate continued influence across genetics and evolutionary sciences.[1]

Abstract

Andrea Manica’s research integrates population genetics, ecology, anthropology, computational biology, and evolutionary theory to investigate biological diversity and human evolutionary history. His work combines large-scale genomic datasets, ecological modelling, and statistical methods to improve understanding of species distributions, migration processes, adaptation, and conservation. His scholarly achievements have resulted in a substantial international research profile with extensive citations and broad interdisciplinary impact.[1][2]

Keywords

Population genetics, evolutionary biology, ecological modelling, biodiversity, human migration, computational biology, conservation genetics, statistical ecology, genomics, species distribution modelling.

Introduction

Modern genetics increasingly relies upon interdisciplinary analytical approaches capable of integrating molecular, ecological, and computational evidence. Andrea Manica’s research exemplifies this trend by combining quantitative analysis with evolutionary theory to address questions concerning biodiversity, adaptation, and demographic history. His work has contributed to both methodological development and biological discovery while supporting evidence-based conservation research.[2]

Research Profile

Andrea Manica is affiliated with the University of Cambridge and maintains an internationally visible publication record indexed in Scopus. His documented scholarly metrics include 187 indexed publications, over 17,000 citations, and an h-index of 67, reflecting consistent scientific influence across multiple research disciplines.[1]

  • Population genetics and demographic inference.
  • Human evolutionary history.
  • Ecological and environmental modelling.
  • Biodiversity and conservation science.
  • Statistical and computational biology.

Research Contributions

His investigations have improved scientific understanding of how evolutionary processes, environmental factors, and migration shape genetic diversity. By integrating computational simulations with empirical observations, his studies have informed research concerning adaptation, population structure, climate influences, and conservation planning.[2][3]

  • Development of computational approaches for population genetics.
  • Analysis of human migration and demographic history.
  • Research supporting biodiversity conservation.
  • Integration of ecological and genomic datasets.
  • Interdisciplinary collaboration across genetics and ecology.

Publications

Andrea Manica has authored numerous peer-reviewed publications appearing in internationally recognized scientific journals. His research articles are frequently cited within genetics, ecology, anthropology, conservation biology, and evolutionary science, reflecting sustained scholarly relevance.[1]

  • Population genetic analyses.
  • Evolutionary modelling studies.
  • Human demographic history research.
  • Biodiversity conservation publications.

Research Impact

The documented citation metrics indicate extensive international recognition of Andrea Manica’s scholarly work. His publications continue to support research across genetics, ecology, anthropology, and environmental sciences while influencing computational methodologies and conservation strategies. The breadth of citations reflects continued relevance across diverse scientific communities.[1]

Award Suitability

Based on publicly available scholarly indicators, Andrea Manica demonstrates characteristics consistent with recognition through an Innovative Research Award. These include a sustained publication record, internationally recognized citation impact, interdisciplinary scientific contributions, methodological innovation, and continued advancement of population genetics and evolutionary biology research. Such accomplishments align with common evaluation criteria used in academic recognition programs.[1]

Conclusion

Andrea Manica’s scholarly career reflects substantial contributions to population genetics, computational biology, biodiversity research, and evolutionary science. Through interdisciplinary collaboration and quantitative innovation, his work has strengthened scientific understanding of biological diversity and evolutionary processes. His documented academic achievements support recognition within international research award programs dedicated to scientific excellence and innovation.[2]

References

    1. Elsevier. (n.d.). Scopus author details: Andrea Manica, Author ID 6603416293. Scopus.https://www.scopus.com/authid/detail.uri?authorId=6603416293
    2. ORCID. (n.d.). Andrea Manica
      ORCID Profile.      https://orcid.org/0000-0003-1895-450X
    3. Manica, A., et al. Representative research publication. Nature.
      DOI:
      https://doi.org/10.1038/nature06258
    4. Elsevier. (n.d.). Google scholar details: Andrea Manica.
      Google scholar. https://scholar.google.com/citations?user=v8V058QAAAAJ&hl=en
    5. An African origin for the intimate association between humans and Helicobacter pylori
       https://www.nature.com/articles/nature05562

Junsong Yang | Genetics and Gnomics | Research Excellence Award

Published on by Global Genetics Award

Prof. Junsong Yang | Genetics and Gnomics | Research Excellence Award

Bengbu Medical University | China

Prof. Junsong Yang, Ph.D., is a Professor at Bengbu Medical University (BBMU), Bengbu, Anhui, China, with nearly two decades of academic and professional service at the institution. He earned his bachelor’s degree in Chemical Process Engineering from East China University of Science and Technology, followed by a Master of Science in Chemistry from the University of Science and Technology of China. He completed his doctoral degree in Chemistry at Anhui University. Over the past eighteen years at BBMU, Professor Yang has been actively engaged in teaching and research, with a strong focus on food quality and safety, contributing to the advancement of applied chemical sciences and public health-oriented education.

Citation Metrics (Scopus)

200
150
100
50
0

Citations
86

Documents
26

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Liu Changlai | Genetic Variation | Excellence Award (Any Scientific field)

Published on by Global Genetics Award

Prof. Liu Changlai | Genetic Variation | Excellence Award 

Nanjing Forestry University | China

Prof. Liu Changlai is a graduate supervisor at Nanjing Forestry University and a distinguished scholar in plant molecular biology and bamboo science. His research centers on the regulation and applied processing of secondary metabolites in bamboo, alongside bamboo population genetics and functional gene development, integrating genomics, transcriptomics, and physiological approaches. Professor Liu has made significant contributions to understanding photosynthesis regulation, stress responses, and transcription factor families across bamboo and other plant species, with impactful studies published in leading journals such as Plants, Industrial Crops and Products, Forests, and Frontiers in Molecular Biosciences. His work spans fundamental gene identification to applied innovations, including medical bamboo product processing and stress-resilient crop improvement. Through sustained, high-quality research output and mentorship, Professor Liu continues to advance plant functional genomics and the sustainable utilization of bamboo resources.

Citation Metrics (Scopus)

300
200
100
50
0

Citations
229

Documents
15

h-index
6

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile View GoogleScholar Profile

Featured Publications

Dongli Pan | Herpesvirus Infection | Best Researcher Award

Published on by Global Genetics Award

Prof. Dr. Dongli Pan | Herpesvirus Infection | Best Researcher Award

Zhejiang University School of Medicine | China

Dr. Prof. Dongli Pan is a distinguished biochemist whose research has significantly advanced the understanding of viral pathogenesis and host-virus interactions. She earned her Ph.D. in Biochemistry from the University of Pennsylvania, Philadelphia (2001–2007), where her dissertation focused on the fast kinetics of tRNA movement on the ribosome during bacterial translation elongation, following a B.S. in Chemistry from Peking University, Beijing (1997–2001). Currently a Professor at the Zhejiang University School of Medicine, Dr. Pan’s major research interests center on the mechanisms of herpes simplex virus (HSV) infection and pathogenesis, HSV-host interactions, and anti-HSV drug development. Her research excellence has been recognized through several competitive national grants, including major projects funded by the National Key R&D Project of China and the National Natural Science Foundation of China, with total funding exceeding several million RMB. Dr. Pan has led and contributed to groundbreaking studies on viral latency, host microRNAs, and innate immune responses to DNA viruses. Before joining Zhejiang University, she conducted postdoctoral research at Harvard Medical School and the University of Pennsylvania, deepening her expertise in molecular virology. In addition to her research, Dr. Pan is a dedicated educator, actively involved in undergraduate and graduate teaching at Zhejiang University and the Zhejiang University–University of Edinburgh Institute, where she organizes and lectures in courses such as Infection 3, Pathogens, and Medical Microbiology and Parasitology, fostering the next generation of biomedical scientists through her bilingual instruction and mentorship.

Profiles: Scopus

Featured Publications

"Inhibitory effect of Alantolactone against varicella-zoster virus in vitro", Virology JournalThis link is disabled., 2025.

"A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing",Nature CommunicationsThis link is disabled., 2025.

"Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication", Journal of Medicinal Chemistry, 2025.

"Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells", J. Virol, 2025.

Ying Wang | Chromosomal Abnormalities | Best Researcher Award

Published on by Global Genetics Award

Dr. Ying Wang | Chromosomal Abnormalities | Best Researcher Award 

Tongji medical college of huazhong university of science and technology | China

Author Profile

Scopus

【YING WANG: A DEDICATED HEMATOLOGY RESEARCHER】

🎓 EARLY ACADEMIC PURSUITS

Ying Wang’s passion for medicine began at a young age, inspiring her to pursue an extensive medical education. She completed eight years of rigorous training, which included five years of clinical medical study followed by three years specializing in hematology. During this time, she developed a strong interest in laboratory science and hematology technology. Her academic journey allowed her to master fundamental hematological knowledge and acquire essential experimental skills such as polymerase chain reaction (PCR), cell culture, and morphology. This foundation led her to continue her professional journey in the hematology laboratory upon graduation.

💼 PROFESSIONAL ENDEAVORS

Since 2008, Ying Wang has been working in the Hematology Laboratory of Tongji Hospital at Tongji Medical College, Huazhong University of Science and Technology. Her career began with a primary focus on cell morphology, which is the cornerstone of hematopathology. Over three years, she gained an in-depth understanding of the characteristics of different hematological testing methods, including morphology, immunology, cytogenetics, and molecular biology.

For the past seven years, her work has been centered on cytogenetics, particularly in chromosomal analysis and fluorescence in situ hybridization (FISH). Through dedicated training and hands-on practice, she has mastered G-banding chromosomal analysis and developed expertise in applying FISH techniques to malignant blood diseases.

Currently, she leads the Cytogenetics Group, overseeing four team members and ensuring the efficiency and accuracy of daily operations. Under her leadership, her team has successfully established cytogenetic analysis for blood diseases and has processed a significant volume of patient samples. Her contributions to the field are reflected in her authorship of two published research papers.

📝 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Ying Wang’s research focuses on cytogenetic analysis in hematology, particularly in the chromosomal abnormalities associated with blood diseases. Her expertise in G-banding chromosomal analysis and FISH techniques has significantly enhanced diagnostic and prognostic capabilities in hematopathology. She has contributed extensively to the establishment and optimization of cytogenetic methodologies in her laboratory, leading to improved patient diagnoses and treatment strategies.

Despite the labor-intensive nature of cytogenetic analysis, she remains deeply passionate about her work. Knowing that her contributions provide crucial diagnostic and prognostic data to clinicians, she continues to dedicate herself to advancing the field of hematology.

🌟 IMPACT AND INFLUENCE

Ying Wang’s work has had a profound impact on the field of hematology, particularly in China. By pioneering cytogenetic analysis for blood diseases in her laboratory, she has played a critical role in improving diagnostic precision. Her leadership in the Cytogenetics Group has enabled her team to process a high volume of patient samples, ensuring timely and accurate results that guide treatment decisions.

Her research contributions have also influenced the broader scientific community through her publications. Additionally, her involvement as a member of the Hubei Medical Biology and Immunology Society demonstrates her commitment to professional collaboration and knowledge exchange within the field.

📊 ACADEMIC CITATIONS

Ying Wang has authored two peer-reviewed research papers focusing on cytogenetics and blood disease analysis. These publications have contributed to the scientific community’s understanding of chromosomal abnormalities in hematology. Her work continues to be cited by researchers working on similar topics, further solidifying her influence in the field.

💪 LEGACY AND FUTURE CONTRIBUTIONS

As she advances in her career, Ying Wang remains committed to furthering her expertise in hematology and cytogenetics. She acknowledges the limitations of her current knowledge and continuously seeks to expand her skills through further studies and international collaborations. She aspires to stay at the forefront of hematological advancements by engaging with leading laboratories worldwide.

Upon completing her further studies, she aims to implement cutting-edge techniques in her laboratory, thereby enhancing the quality and scope of cytogenetic analysis available to patients in China. Her long-term vision is to contribute to the continued evolution of hematology research and to provide even more precise and valuable diagnostic information for improved patient outcomes.

👨‍🎓 POSITIONS AND HONORS

  • 2008 – Present: Hematology Laboratory, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (Specialized in Morphology and Cytogenetics).
  • 2017 – Present: Member, Hubei Medical Biology and Immunology Society, China.

📑NOTABLE PUBLICATIONS

"Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation" 

  • Authors: X., Kong, Xin , Z., Xu, Ziyi , Y., Wu, Yanjun , Y., Zhao, Ye , F., Chen, Feng
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

" Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial " 

  • Authors: J., Lu, Jing , H., Qiu, Huiying , Y., Wang, Ying , Y., Zhu, Yu , S., Chen, Suning
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

"CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia" 

  • Authors: Y., Yao, Yao , J., Zhou, Jin , Y., Li, Yanting , D.P., Wu, De Pei , Y., Wang, Ying
  • Journal: Annals of Hematology
  • Year: 2024

"Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome " 

  • Authors: S., Guo, Shiqi , D., Xie, Dan , Y., Gao, Ye , Y., Wang, Ying , Q., Guo, Qiang
  • Journal: BMC Pulmonary Medicine
  • Year: 2024

"A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China " 

  • Authors: Y., Wang, Ying , D.P., Wu, De Pei , X., Zhang, Xiang , Y., Wang, Yu , Y., Zhang, Ying
  • Journal: BMC Medicine
  • Year: 2024

Yani Arhab | Viral Strategies | Best Researcher Award

Published on by Global Genetics Award

Dr. Yani Arhab | Viral Strategies | Best Researcher Award

SUNY Downstate Health Sciences University | United States

Author Profile

Scopus

Orcid ID

Google Scholar

YANI ARHAB, PHD 🎓🔬

EARLY ACADEMIC PURSUITS 📚

Yani Arhab’s academic journey began at the University François Rabelais of Tours (France), where he earned his BSc in Biology. During his studies, he participated in an Erasmus program, studying at Queen Mary University of London. He continued his education at University Claude Bernard Lyon1, completing his Master's in Structural & Functional Biochemistry. Yani further honed his skills during a Master’s 2 training at the ICBMS, where he worked on the structural and functional characterization of phospholipases D in plants.

PROFESSIONAL ENDEAVORS 💼

Yani's career spans multiple prestigious institutions and roles. From 2015 to 2018, he earned his PhD at the University of Lyon, where he focused on phospholipases D, under the guidance of Pr. A. Abousalham and Dr. A. Noiriel. Following this, he served as a full-time associate professor at Université Claude Bernard Lyon1 in 2018-2019. Since 2019, Yani has been a Postdoctoral Associate at the State University of New York, Downstate Medical Center, where he is studying the reconstitution of ribosomal initiation complexes on viral RNA Internal Ribosome Entry Sites (IRES) under the mentorship of Dr. Christopher Hellen and Dr. Tatyana Pestova.

CONTRIBUTIONS AND RESEARCH FOCUS ON VIRAL STRATEGIES🧬

Yani’s research focuses on biochemistry, particularly in the areas of ribosomal initiation, lipid biochemistry, and the structural and functional analysis of enzymes. His work on phospholipases D has contributed significantly to understanding lipid metabolism and its impact on cellular functions. In his current research, he is studying viral RNA IRES and their mechanisms in translation initiation, which has important implications for viral infections and potential therapeutic targets.

IMPACT AND INFLUENCE 🌍

Yani’s work is influencing multiple fields of molecular biology and biochemistry, particularly through his contributions to understanding the molecular mechanisms behind viral translation and enzyme function. His research on IRES mechanisms is helping expand our knowledge of viral RNA translation, with the potential to influence future antiviral strategies.

ACADEMIC CITATIONS 📈

Throughout his academic career, Yani Arhab has gained recognition for his innovative research, presenting his findings at international conferences such as the Translational Control Symposium at Cold Spring Harbor Laboratory and the Ribosome Structure & Function Conference. His research contributions have resulted in numerous publications and are frequently cited by peers in the fields of biochemistry, molecular biology, and virology.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Yani Arhab’s legacy is defined by his commitment to advancing our understanding of molecular biology. He has built a solid foundation of research that will continue to shape the future of biochemical research, particularly in the fields of RNA biology and viral research. Looking ahead, he plans to further investigate the complex interactions of ribosomal initiation and their implications for therapeutic development, particularly for viral diseases.

AWARDS AND SCHOLARSHIPS 🏆

  • 2015, 2016, 2018: Research funds from the Ligue National Contre le Cancer (€15,000)
  • 2017: FEBS+3 travel grant (€750)
  • 2015: Ph.D. bursary recipient

PROFESSIONAL MEMBERSHIPS 🤝

  • Member of the AFC (French Crystallography Society)
  • Member of the SFBBM (French Molecular Biology and Biochemistry Society)
  • Associate Professor in Biochemistry and Molecular Biology since 2019

TEACHING EXPERIENCE 🍎

Yani Arhab has contributed to the education of future scientists by teaching both lectures and experimental courses in biochemistry. He has mentored undergraduate students in subjects such as protein purification, lipid characterization, and enzymatic assays, fostering the next generation of researchers. Yani Arhab's work exemplifies the intersection of molecular research and practical application in medicine, showcasing his contributions to both academia and the scientific community at large.

NOTABLE PUBLICATIONS 📑

"Heterologous expression, kinetic characterization and molecular modeling of a new sn-1,3-regioselective triacylglycerol lipase from Serratia sp. W3" 

  • Authors: Eddehech, A. , Rahier, R. , Smichi, N. , Sayari, A. , Zarai, Z.
  • Journal: Process Biochemistry
  • Year: 2021

"Phospholipase D inhibitors screening: Probing and evaluation of ancient and novel molecules" 

  • Authors: Arhab, Y. , Bessaa, K. , Abla, H. , Abousalham, A. , Noiriel, A
  • Journal: International Journal of Biological Macromolecules
  • Year: 2021

"Corrigendum to “Production, purification and functional characterization of phospholipase C from Bacillus thuringiensis with high catalytic activity”

  • Authors: Eddehech, A. , Smichi, N. , Arhab, Y. , Gargouri, Y. , Zarai, Z.
  • Journal: Process Biochemistry
  • Year: 2019

"Production, purification and functional characterization of phospholipase C from Bacillus thuringiensis with high catalytic activity" 

  • Authors: Eddehech, A. , Smichi, N. , Arhab, Y. , Gargouri, Y. , Zarai, Z.
  • Journal: Process Biochemistry
  • Year: 2019

"Plant phospholipase D mining unravels new conserved residues important for catalytic activity" 

  • Authors: Arhab, Y. , Abousalham, A. , Noiriel, A.
  • Journal: Molecular and Cell Biology of Lipids
  • Year: 2019

Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Published on by Global Genetics Award

Prof Dr. Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Nanjing Medical University | China

AUTHOR PROFILE

Scopus

orcid ID

EARLY ACADEMIC PURSUITS

Wei Wu began his academic journey at Nanjing Medical University, where he earned a Bachelor of Science in Preventive Medicine in 2007. He continued his studies at the same institution, obtaining a Ph.D. in Toxicology in 2012. His doctoral research was conducted in the Department of Toxicology, focusing on toxicological mechanisms and their implications for public health. Following his Ph.D., Wu completed a postdoctoral fellowship in Reproductive and Developmental Toxicology at the State Key Laboratory of Reproductive Medicine, also at Nanjing Medical University. In 2017-2018, he broadened his research horizons as a guest researcher at the National Institute of Environmental Health Sciences in the United States, specializing in Epidemiology.

PROFESSIONAL ENDEAVORS

Wei Wu's professional career is anchored at Nanjing Medical University, where he has ascended from a research assistant to a professor. His roles include:

  • 2022-present: Professor, Department of Toxicology, School of Public Health
  • 2022-present: Assistant Dean, School of Public Health
  • 2022-present: Secretary General, Jiangsu Society of Toxicology
  • 2021-present: Associate Department Chair, Department of Scientific Research Sharing Platform (Core Facility)
  • 2018-present: Associate Department Chair, Department of Toxicology
  • 2016-2022: Associate Professor, Department of Toxicology
  • 2012-2016: Lecturer, Department of Toxicology
  • 2010-2012: Research Assistant, School of Public Health

CONTRIBUTIONS AND RESEARCH FOCUS ON DNA METHYLATION AND MALE REPRODUCTIVE HEALTH

Wei Wu has made significant contributions to the field of toxicology, particularly in reproductive and developmental toxicology. His research has focused on the toxicological effects of environmental and chemical exposures on reproductive health. His work also delves into the molecular mechanisms underlying these toxicological impacts, aiming to develop preventive strategies and therapeutic interventions.

IMPACT AND INFLUENCE

Wei Wu has received numerous honors and awards that reflect his impact and influence in the field of toxicology. Notable accolades include:

  • 2023: "Good Youth Around Us" by the Communist Youth League Jiangsu Provincial Committee
  • 2022: Friendship Teaching Award of Nanjing Medical University
  • 2020: Ministry of Education Fok Ying Tung Young Teachers' Award
  • 2019: Clarivate Publons Peer Review Awards (top 1% reviewers in Crossfield and Clinical Medicine)
  • 2018: Publons Peer Review Awards (top 1% reviewers in Clinical Medicine)
  • 2017: Multiple awards for excellent papers and teaching achievements

ACADEMIC CITATIONS

Wei Wu holds various editorial positions, contributing to the dissemination of scientific knowledge in toxicology and related fields. He serves on the editorial boards of several prestigious journals, including:

  • Scientific Reports
  • SM Journal of Environmental Toxicology
  • Global Journal of Genitourinary Cancer
  • Austin Journal of Reproductive Medicine & Infertility
  • Journal of Clinical Obstetrics, Gynecology & Infertility
  • Medicine
  • Frontiers in Endocrinology
  • Frontiers in Physiology

As an editor-in-chief, he leads the International Journal of Sexual Health and Reproductive Health Care and the Research International Journal of Endocrinology and Diabetes.

LEGACY AND FUTURE CONTRIBUTIONS

Wei Wu’s ongoing research and professional activities suggest a lasting legacy in the field of toxicology. His leadership roles within professional societies, such as the Jiangsu Society of Toxicology and the Jiangsu Provincial Preventive Medical Association, underline his influence in shaping future research directions and policies. His dedication to teaching and mentoring the next generation of toxicologists ensures that his impact will continue to resonate in the academic and scientific communities.

NOTABLE PUBLICATIONS

Cohort Profile: The Jiangsu Birth Cohort 2023(3)

Effect of prenatal perfluoroheptanoic acid exposure on spermatogenesis in offspring mice 2023(4)

Adverse effect of assisted reproductive technology-related hyperoestrogensim on the secretion and absorption of uterine fluid in superovulating mice during the peri-implantation period 2023(2)

Association between prenatal perfluorinated compounds exposure and risk of pregnancy complications: A meta-analysis 2024

Effect of prenatal exposure to phthalates on birth weight of offspring: A meta-analysis 2024